Spectranetics announced an agreement to purchase the assets of Upstream Peripheral Technologies, an affiliate of ARAN Research Development & Prototypes, for up-front consideration of $5.5M with additional milestone payments tied to revenue, manufacturing transfer, and other milestones specified in the asset purchase agreement. Included in the acquisition are unique technologies that expand Spectranetics' Vascular Intervention portfolio.
As traders wait on the Federal Reserve, putting off any major decisions until they hear the latest word in FOMC …